|
[1] LEWIS HL,RAHNEMAI-AZAR AA,DILLHOFF M,et al. Current Management of Perihilar Cholangiocarcinoma and Future Perspectives[J]. Chirurgia(Bucur),2017,112(3):193-207.
|
|
[2] XIONG J,NUNES QM,HUANG W,et al. Major hepatectomy in Bismuth types I and II hilarcholangiocarcinoma[J]. Surg Res,2015,194(1):194-201.
|
|
[3] FURUSAWA N,KOBAYASHI A,YOKOYAMA T,et al. Surgical treatment of 144 cases of hilarcholangiocarcinoma without liverrelated mortality[J]. World J Surg,2014,38(5):1164-1176.
|
|
[4] JI GW,ZHU FP,WANG K,et al. Clinical implications of biliary confluence pattern for bismuth-corlette typeⅣhilar cholangiocarcinoma applied to hemihepatectomy[J]. J Gastrointest Surg,2017,21(4):666-675.
|
|
[5] CROOME KP,ROSEN CB,HEIMBACH JK,et al. Is liver transplantation appropriate for patients with potentially resectable de novo hilarcholangiocarcinoma?[J]. J Am Coll Surg,2015,221(1):130-139.
|
|
[6] GOVIL S,REDDY MS,RELA M. Surgical resection techniques for locally advanced hilarcholangiocarcinoma[J]. Langenbecks Arch Surg,2014,399(6):707-716.
|
|
[7] XIANG S,LAU WY,CHEN XP. Hilarcholangiocarcinoma:Controversies on the extent of surgical resection aiming at cure[J]. Int J Colorectal Dis,2015,30(2):159-171.
|
|
[8] CHEN W,KE K,CHEN YL. Combined portal vein resection in the treatment of hilarcholangiocarcinoma:A systematic review and meta-analysis[J]. Eur J Surg Oncol,2014,40(5):489-495.
|
|
[9] BLECHACZ B. Cholangiocarcinoma:Current knowledge and new developments[J]. Gut Liver,2017,11(1):13-26.
|
|
[10] KIMBROUGH CW,CLOYD JM,PAWLIK TM. Surgical approaches for the treatment of perihilarcholangiocarcinoma[J]. Expert Rev Anticancer Ther,2018,18(7):673-683.
|
|
[11] KU D,TANG R,PANG T,et al. Survival outcomes of hepatic resections in Bismuth-Corlette type IV cholangiocarcinoma[J]. ANZ J Surg,2019.[Online ahead of print]
|
|
[12] LI XC,FENG QC. Advance and controversy of hilarcholangiocarcinoma[J]. J Clin Hepatol,2019,35(12):2632-2637.(in Chinese)李相成，冯勤超．肝门部胆管癌的进展与争议[J]．临床肝胆病杂志，2019,35(12):2632-2637.
|
|
[13] JOO I,LEE JM,YOON JH. Imaging diagnosis of intrahepatic and perihilarcholangiocarcinoma:Recent advances and challenges[J]. Radiology,2018,288(1):7-13.
|
|
[14] LEE HY,KIM SH,LEE JM,et al. Preoperative assessment of resectability of hepatic hilarcholangiocarcinoma:Combined CT and cholangiography with revised criteria[J]. Radiology,2006,239(1):113-121.
|
|
[15] TANG Z,YANG Y,MENG W,et al. Best option for preoperative biliary drainage in Klatskin tumor:A systematic review and meta-analysis[J]. Medicine(Baltimore),2017,96(43):e8372.
|
|
[16] HUANG ZQ. Change in the opinion of surgical treatment strategy of hepartic portal cholangiocarcinoma[J]. J Clin Surg,2008,16(1):3-4.(in Chinese)黄志强．肝门部胆管癌外科治疗观念能否有所转变[J]．临床外科杂志，2008,16(1):3-4.
|
|
[17] RIBERO D,ZIMMITTI G,ALOIA TA,et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilarcholangiocarcinoma[J]. J Am Coll Surg,2016,223(1):87-97.
|
|
[18] DONG JH,ZHENG SS,CHEN XP,et al. Consensus on evaluation of hepatic functionalreserve before hepatectomy(2011 edition)[J]. Chin J Dig Surg,2011,10(1):20-25.(in Chinese)董家鸿，郑树森，陈孝平，等．肝切除术前肝脏储备功能评估的专家共识(2011版)[J]．中华消化外科杂志，2011,10(1):20-25.
|
|
[19] GLANTZOUNIS GK,TOKIDIS E,BASOURAKOS SP,et al.The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review[J]. Eur J SurgOncol,2017,43(1):32-41.
|
|
[20] HUA CC,LIU Y,YIN QH. The study of accurate liver volume measurement byIQQA-liver auto analysis software[J]. CT Theory Appl,2019,28(2):229-236.(in Chinese)华晨辰，刘垚，尹其华．IQQA-liver自动分析软件在肝脏体积精确测量方面的应用研究[J]. CT理论与应用研究，2019,28(2):229-236.
|
|
[21] AOBA T,EBATA T,YOKOYAMA Y,et al. Assessment of nodal status for perihilarcholangiocarcinoma:Location,number,or ratio of involved nodes[J]. Ann Surg,2013,257(4):718-725.
|
|
[22] WANG Y,YANG H,SHEN C,et al. Surgical procedure and long-term survival of hilarcholangiocarcinoma[J]. Int J Clin Exp Med,2015,8(1):1122-1128.
|
|
[23] LU Z,WANG DD. Operation treatment method of BismuthCorletteⅢ，Ⅳhilarcholangiocarcinoma[J]. Chin J Surg,2016,54(7):488-491.(in Chinese)鲁正，王冬冬．Bismuth-CorletteⅢ、Ⅳ型肝门部胆管癌的手术治疗方式[J]．中华外科杂志，2016,54(7):488-491.
|
|
[24] HONG SS,HAN DH,CHOI GH,et al. Comparison study for surgical outcomes of right versus left side hemihepatectomy to treat hilarcholangiocellular carcinoma[J]. Ann Surg Treat Res,2020,98(1):15-22.
|
|
[25] KOW AWC,WOOK CD,SONG SC,et al. Role of caudate lobectomy in type III A and III B hilarcholangiocarcinoma:A 15-year experience in a tertiary institution[J]. World J Surg,2012,36(5):1112-1121.
|
|
[26] GAZZANIGA GM,FILAURO M,BAGAROLO C,et al. Surgery for hilarcholangiocarcinoma:An Italian experience[J]. J Hepatobiliary Pancreat Surg,2000,7(2):122-127.
|
|
[27] LU CD,HUANG J,WU SD,et al. Total hilar en bloc resection with left hemihepatectomy and caudate lobectomy:A novel approach for treatment of left-sided perihilarcholangiocarcinoma(with video)[J]. J Gastrointest Surg,2017,21(11):1906-1914.
|
|
[28] SCHIMIZZI GV,JIN LX,DAVIDSON JT,et al. Outcomes after vascular resection during curative-intent resection for hilarcholangiocarcinoma:A multi-institution study from the US extrahepatic biliary malignancy consortium[J]. HPB(Oxford),2018,20(4):332-339.
|
|
[29] MATSUYAMA R,MORI R,OTA Y,et al. Significance of vascular resection and reconstruction in surgery for hilarcholangiocarcinoma:With special reference to hepatic arterial resection and reconstruction[J]. Ann Surg Oncol,2016,23(Suppl 4):475-484.
|
|
[30] LIU QH,WANG L,CHU YK,et al. Diagnosis and treatment of surgical resection for 87 cases of hilarcholangiocarcinoma[J].Chin J Gastroenterol Hepatol,2018,27(7):804-807.(in Chinese)刘清华，汪凌，褚延魁，等．87例肝门部胆管癌手术切除的诊疗分析[J]．胃肠病学和肝病学杂志，2018,27(7):804-807.
|
DownLoad: